Skip to content
PubMed This is a summary of 5 peer-reviewed journal articles Updated
Endocrinology · Cortisone Reductase Deficiency

Building Your Knowledge of Cortisone Reductase Deficiency

At a Glance

Cortisone reductase deficiency is a rare genetic condition that makes the body process cortisol abnormally and produce extra androgens, causing early puberty signs in children or acne and irregular periods in adults. A 24-hour urine steroid profile helps distinguish it from similar conditions.

Learning that you or your child has a condition as rare as Cortisone Reductase Deficiency (CRD)—also known as Apparent Cortisone Reductase Deficiency (ACRD)—can feel overwhelming. Because the condition is so rare that it is mostly documented in individual case reports and small series, finding clear information can be difficult [1][2].

ACRD is a genetic disorder that affects how the body manages the hormone cortisol. In a healthy body, an enzyme called 11β-HSD1 converts inactive cortisone back into active cortisol [1]. In ACRD, this conversion process is impaired, typically due to mutations in either the HSD11B1 gene or the H6PD gene [1]. Because the body cannot regenerate cortisol efficiently, cortisol is cleared from the blood too quickly [2]. The brain compensates for this by signaling the adrenal glands to work harder. This leads to adrenocortical hyperactivity, where the adrenal glands produce more cortisol to keep up but also overproduce androgens (hormones like testosterone) [1][2].

How ACRD Shows Up

The symptoms of ACRD depend largely on the age at which they appear. While the underlying mechanism is the same, the physical effects change as a person grows.

  • In Childhood (Premature Pubarche): Children with ACRD often experience premature pubarche, which is the early appearance of pubic or underarm hair, body odor, or acne before the typical age of puberty [2]. Parents may also notice a rapid “growth spurt.” However, the elevated androgens can cause advanced bone age, meaning the skeleton matures too quickly, which may lead to a shorter adult height if not managed [2].
  • In Adult Females (Hyperandrogenism): In women, excess androgens can cause symptoms that mimic other conditions. These include persistent acne, excess facial or body hair (hirsutism), irregular menstrual cycles, and potentially difficulties with fertility due to a lack of regular ovulation [1][3].

Common Misunderstandings

Because ACRD is so rare, it is frequently confused with more common endocrine disorders. Clearing up these misunderstandings is a vital part of your care journey.

  • ACRD vs. PCOS: In adult women, ACRD is often mistaken for Polycystic Ovary Syndrome (PCOS) because both can cause irregular periods and excess hair growth. However, the root cause of ACRD is an enzyme deficiency in the adrenal glands [4]. It is important to know that PCOS and ACRD can sometimes coexist, and having polycystic-appearing ovaries does not rule out ACRD.
  • ACRD vs. CAH: ACRD can also be confused with Congenital Adrenal Hyperplasia (CAH), specifically the “non-classic” form. Both involve high levels of androgens and the hormone 17-hydroxyprogesterone [2]. The key difference lies in the urinary steroid profile, a specialized test that measures the ratio of cortisol to cortisone metabolites [2][5].
  • Fears of Adrenal Insufficiency: Unlike “classic” CAH, where the body cannot make enough cortisol to survive an illness (adrenal crisis), ACRD itself typically involves the body making cortisol but clearing it too quickly [2]. However, the treatment for ACRD often involves glucocorticoids, which can suppress your natural cortisol production over time, making it crucial to have a sick-day stress-dosing plan.

Diagnosis and Management

Diagnosis usually integrates clinical findings with a 24-hour urine collection to perform gas chromatography-mass spectrometry (GC-MS) [5]. This highly sensitive test maps out the various hormones and metabolites in the urine, allowing doctors to see the specific “fingerprint” of impaired cortisone-to-cortisol conversion [5][2]. Genetic testing may also be recommended, though a negative result does not always rule out the disease. Genetic counseling can help you understand family-planning implications.

Management is highly individualized. For children, the goal is often to suppress the excess androgens to protect their final adult height and manage early physical changes [2]. For adults, the focus may be on skin health, regulating cycles, or family planning. Because treatment options are based on limited case reports, your endocrinologist will carefully select and titrate the medication based on your individual response and to minimize side effects [2]. Regular monitoring of growth, bone age, and hormone levels is essential to ensure the balance is right for your specific needs [2].

Common questions in this guide

What is apparent cortisone reductase deficiency (ACRD)?
ACRD is a rare genetic disorder in which the body does not efficiently convert inactive cortisone into active cortisol. Cortisol is cleared too quickly, prompting the adrenal glands to work harder and produce excess androgens.
What signs might ACRD cause in a child or adult?
Children may develop pubic or underarm hair, body odor, acne, rapid growth, and advanced bone age earlier than expected. Adult women may have acne, excess facial or body hair, irregular periods, and difficulty becoming pregnant.
How do doctors tell ACRD apart from PCOS or nonclassic CAH?
Doctors combine symptoms and hormone results with a 24-hour urinary steroid profile analyzed by GC-MS, which examines cortisol and cortisone metabolites. This pattern can help distinguish ACRD from PCOS and nonclassic congenital adrenal hyperplasia, which can cause similar androgen-related symptoms. Genetic testing may provide additional support, but PCOS can coexist and polycystic-appearing ovaries do not exclude ACRD.
Does ACRD cause adrenal insufficiency or an adrenal crisis?
ACRD itself usually means the body makes cortisol but clears it too quickly, rather than being unable to make enough cortisol as in classic congenital adrenal hyperplasia. However, glucocorticoid treatment can suppress natural cortisol production over time, so the treating clinician may provide a sick-day stress-dosing plan.
Are HSD11B1 and H6PD genetic tests needed for an ACRD diagnosis?
Testing these genes may support the diagnosis and help with family-planning discussions, but a negative result does not always rule out ACRD. A genetic counselor or endocrinologist can explain what the test can and cannot show.
How is ACRD treated and monitored?
Treatment is individualized and often uses glucocorticoids to reduce excess adrenal androgen production. In children, goals may include slowing bone maturation and protecting adult height; in adults, treatment may focus on acne, hair growth, menstrual cycles, or fertility. Clinicians monitor growth, bone age, and hormone levels and adjust medicine to limit side effects.

Get notified when new evidence is published on Hyperandrogenism due to cortisone reductase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (5)
  1. 1

    Alterations of Cortisol Metabolism in Human Disorders.

    White PC

    Hormone research in paediatrics 2018; (89(5)):320-330 doi:10.1159/000485508.

    PMID: 29843121
  2. 2

    A follow-up history of young man with apparent cortisone reductase deficiency (ACRD) - several years after diagnosis.

    Zajkowska A, Rydzewska M, Wojtkielewicz K, et al.

    Pediatric endocrinology, diabetes, and metabolism 2017; (23(1)):42-48 doi:10.18544/PEDM-23.01.0073.

    PMID: 29073307
  3. 3

    Influence of Genotype and Hyperandrogenism on Sexual Function in Women With Congenital Adrenal Hyperplasia.

    Schernthaner-Reiter MH, Baumgartner-Parzer S, Egarter HC, et al.

    The journal of sexual medicine 2019; (16(10)):1529-1540 doi:10.1016/j.jsxm.2019.07.009.

    PMID: 31447379
  4. 4

    Cortisol-Metabolizing Enzymes in Polycystic Ovary Syndrome.

    Blumenfeld Z, Kaidar G, Zuckerman-Levin N, et al.

    Clinical medicine insights. Reproductive health 2016; (10()):9-13 doi:10.4137/CMRH.S35567.

    PMID: 27168731
  5. 5

    Estimation of reference curves for the urinary steroid metabolome in the first year of life in healthy children: Tracing the complexity of human postnatal steroidogenesis.

    Dhayat NA, Frey AC, Frey BM, et al.

    The Journal of steroid biochemistry and molecular biology 2015; (154()):226-36.

    PMID: 26297192

This page is for informational purposes only and does not constitute medical advice or a diagnosis. Your endocrinologist should interpret hormone testing and individualize treatment, including any glucocorticoid or sick-day plan.